Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael P Agius

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Chemistry & Biology|May 27, 2014
Modulating noncatalytic function with kinase inhibitorsMichael P Agius, Matthew B Soellner
Chemical Communications (Cambridge, England)|February 23, 2022
Conformation-tunable ATP-competitive kinase inhibitorsMichael P Agius, Kristin Ko, Taylor K Johnson, et al.
Bioorganic & Medicinal Chemistry Letters|December 25, 2013
Synthesis and evaluation of 4-substituted piperidines and piperazines as balanced affinity μ opioid receptor (MOR) agonist/δ opioid receptor (DOR) antagonist ligandsAaron M Bender, Mary J Clark, Michael P Agius, et al.
Angewandte Chemie (International Ed. in English)|October 25, 2022
Reply to Correspondence on "Synergy and Antagonism between Allosteric and Active-Site Inhibitors of Abl Tyrosine Kinase"Taylor K Johnson, Daniel A Bochar, Nathalie M Vandecan, et al.
Angewandte Chemie (International Ed. in English)|July 22, 2021
Synergy and Antagonism between Allosteric and Active-Site Inhibitors of Abl Tyrosine KinaseTaylor K Johnson, Daniel A Bochar, Nathalie M Vandecan, et al.
ACS Chemical Biology|July 10, 2019
Selective Proteolysis to Study the Global Conformation and Regulatory Mechanisms of c-Src KinaseMichael P Agius, Kristin S Ko, Taylor K Johnson, et al.
International Journal of Radiation Oncology, Biology, Physics|July 8, 2020
Anti-MUC1-C Antibody-Conjugated Nanoparticles Potentiate the Efficacy of Fractionated Radiation TherapyAlexandre Detappe, Clélia Mathieu, Caining Jin, et al.
Journal of Medicinal Chemistry|February 27, 2014
X-ray structural and biological evaluation of a series of potent and highly selective inhibitors of human coronavirus papain-like proteasesYahira M Báez-Santos, Scott J Barraza, Michael W Wilson, et al.
Polymer Chemistry|April 1, 2021
Pro-organic radical contrast agents ("pro-ORCAs") for real-time MRI of pro-drug activation in biological systemsHung V-T Nguyen, Alexandre Detappe, Peter Harvey, et al.
Nature Nanotechnology|January 26, 2023
Molecular bottlebrush prodrugs as mono- and triplex combination therapies for multiple myelomaAlexandre Detappe, Hung V-T Nguyen, Yivan Jiang, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Chemistry & Biology|May 27, 2014
Modulating noncatalytic function with kinase inhibitorsMichael P Agius, Matthew B Soellner
Chemical Communications (Cambridge, England)|February 23, 2022
Conformation-tunable ATP-competitive kinase inhibitorsMichael P Agius, Kristin Ko, Taylor K Johnson, et al.
Bioorganic & Medicinal Chemistry Letters|December 25, 2013
Synthesis and evaluation of 4-substituted piperidines and piperazines as balanced affinity μ opioid receptor (MOR) agonist/δ opioid receptor (DOR) antagonist ligandsAaron M Bender, Mary J Clark, Michael P Agius, et al.
Angewandte Chemie (International Ed. in English)|October 25, 2022
Reply to Correspondence on "Synergy and Antagonism between Allosteric and Active-Site Inhibitors of Abl Tyrosine Kinase"Taylor K Johnson, Daniel A Bochar, Nathalie M Vandecan, et al.
Angewandte Chemie (International Ed. in English)|July 22, 2021
Synergy and Antagonism between Allosteric and Active-Site Inhibitors of Abl Tyrosine KinaseTaylor K Johnson, Daniel A Bochar, Nathalie M Vandecan, et al.
ACS Chemical Biology|July 10, 2019
Selective Proteolysis to Study the Global Conformation and Regulatory Mechanisms of c-Src KinaseMichael P Agius, Kristin S Ko, Taylor K Johnson, et al.
International Journal of Radiation Oncology, Biology, Physics|July 8, 2020
Anti-MUC1-C Antibody-Conjugated Nanoparticles Potentiate the Efficacy of Fractionated Radiation TherapyAlexandre Detappe, Clélia Mathieu, Caining Jin, et al.
Journal of Medicinal Chemistry|February 27, 2014
X-ray structural and biological evaluation of a series of potent and highly selective inhibitors of human coronavirus papain-like proteasesYahira M Báez-Santos, Scott J Barraza, Michael W Wilson, et al.
Polymer Chemistry|April 1, 2021
Pro-organic radical contrast agents ("pro-ORCAs") for real-time MRI of pro-drug activation in biological systemsHung V-T Nguyen, Alexandre Detappe, Peter Harvey, et al.
Nature Nanotechnology|January 26, 2023
Molecular bottlebrush prodrugs as mono- and triplex combination therapies for multiple myelomaAlexandre Detappe, Hung V-T Nguyen, Yivan Jiang, et al.
Pageof 2